Zymeworks (ZYME) Receivables (2021 - 2026)

Zymeworks has disclosed Receivables across 6 years of filings, most recently posting $6.2 million for Q1 2026.

• Receivables for Q1 2026 came in at $6.2 million, down 74.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.2 million (down 74.88% YoY), and the FY2025 annual result was $7.4 million, down 86.78% from the prior year.
• Receivables came in at $6.2 million for Q1 2026 at Zymeworks, down from $7.4 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $69.9 million in Q1 2023 to a low of $3.2 million in Q2 2025.
• The 5-year median for Receivables is $30.3 million (2025), against an average of $31.1 million.
• Across the five-year window, Receivables soared 591.54% in 2023 and slumped 90.03% in 2025, its largest moves.
• Zymeworks' Receivables stood at $36.4 million in 2022, then plunged by 46.49% to $19.5 million in 2023, then soared by 187.08% to $55.9 million in 2024, then slumped by 86.78% to $7.4 million in 2025, then slipped by 15.72% to $6.2 million in 2026.
• The last three Receivables figures came in at $6.2 million (Q1 2026), $7.4 million (Q4 2025), and $30.3 million (Q3 2025), per Business Quant data.